Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_imr90ipsc_promoter_p_PM_12_51_13			4	0.6	9.45E-05	CBR1	15-hydroxyprostaglandin dehydrogenase (NADP+) activity [MF], prostaglandin-E2 9-reductase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_185_10			3	0.6	1.88E-04	ABAT, CHRNB2	response to nicotine [BP], response to cocaine [BP]
CG_imr90ipsc_promoter_p_PM_12_250_11			1	0.2	1.11E-04	RSAD1, CACNA1D	voltage-gated calcium channel activity involved in regulation of SA node cell action potential [MF], voltage-gated calcium channel activity involved in regulation of cardiac muscle cell action potential [MF], membrane repolarization involved in regulation of SA node cell action potential [BP], coproporphyrinogen oxidase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_319_13			2	0.4	2.08E-04	GATA3, BMP15, FAH	negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP], positive regulation of T cell differentiation [BP], granulosa cell development [BP], negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP], negative regulation of cell proliferation involved in mesonephros development [BP], regulation of CD4-positive, alpha-beta T cell differentiation [BP], regulation of histone H3-K27 methylation [BP], fumarylacetoacetase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_245_17			2	0.4	4.77E-05	SQLE, NNT	squalene monooxygenase activity [MF], NAD(P)+ transhydrogenase (AB-specific) activity [MF], NAD(P)+ transhydrogenase (B-specific) activity [MF]
CG_imr90ipsc_promoter_p_PM_12_379_6			2	0.4	5.50E-05	MAP2K1, AANAT	receptor signaling protein tyrosine phosphatase activity [MF], aralkylamine N-acetyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_115_6			1	0.2	2.39E-05	IFIT5, UAP1, DPEP1, AIF1L	UDP-N-acetylglucosamine diphosphorylase activity [MF], metallodipeptidase activity [MF], cellular lactam catabolic process [BP], ruffle membrane [CC]
CG_imr90ipsc_promoter_p_PM_14_11_8			2	0.4	2.89E-05	SLC25A3, BRCA2, PLEKHG6, PGS1, NDE1	centrosome duplication [BP], BRCA2-MAGE-D1 complex [CC], phosphate ion carrier activity [MF], cleavage furrow [CC], CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_442_13			1	0.2	4.35E-05	ALOX5AP	leukotriene production involved in inflammatory response [BP]
CG_imr90ipsc_promoter_p_PM_12_276_23			3	0.6	1.70E-04	ALDH1A3, FBLN2	nucleus accumbens development [BP], positive regulation of cell-substrate adhesion [BP]
CG_imr90ipsc_promoter_p_PM_12_117_8			2	0.4	1.42E-04	ARF6, TUBB, HLA-DQA1, IL1R2, CCL11	positive regulation of actin filament polymerization [BP], protein polymerization [BP], immune response [BP]
CG_imr90ipsc_promoter_p_PM_12_340_13			3	0.6	3.97E-05	SEC61B	epidermal growth factor binding [MF], endoplasmic reticulum Sec complex [CC]
CG_imr90ipsc_promoter_p_PM_12_64_13			2	0.4	1.54E-04	FOXK1, AZU1, FOXD2	positive regulation of fractalkine biosynthetic process [BP], positive regulation of interleukin-1 beta biosynthetic process [BP], DNA binding, bending [MF]
CG_imr90ipsc_promoter_p_PM_12_113_9			3	0.6	6.69E-05	SHBG	primary spermatocyte growth [BP]
CG_imr90ipsc_promoter_p_PM_14_38_18			2	0.4	4.22E-05	TBC1D25, TRIB3, CDC42	epidermal growth factor receptor signaling pathway [BP], negative regulation of epidermal growth factor receptor signaling pathway [BP], actin filament branching [BP], regulation of autophagic vacuole maturation [BP]
CG_imr90ipsc_promoter_p_PM_12_155_10			2	0.4	8.89E-05	D2HGDH, AGXT, CYP1A2	oxidative deethylation [BP], toxin biosynthetic process [BP], (R)-2-hydroxyglutarate dehydrogenase activity [MF], serine-pyruvate transaminase activity [MF], oxalic acid secretion [BP]
CG_imr90ipsc_promoter_p_PM_12_202_10			3	0.6	7.81E-05	SOX4, COASY	positive regulation of N-terminal peptidyl-lysine acetylation [BP], pantetheine-phosphate adenylyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_285_8			5	0.8	2.35E-04	OPRL1	nociceptin receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_438_12			2	0.4	1.85E-05	PALM	D3 dopamine receptor binding [MF], negative regulation of dopamine receptor signaling pathway [BP]
CG_imr90ipsc_promoter_p_PM_16_20_11			2	0.4	7.13E-05	SRF, PARD6B, IVD	contractile actin filament bundle assembly [BP], isovaleryl-CoA dehydrogenase activity [MF], tight junction assembly [BP]
CG_imr90ipsc_promoter_p_PM_16_1_103			6	1.0	7.08E-05	GARNL3, TELO2, MOV10L1, TRNT1, PEX14, ANO5	intracellular [CC]
CG_imr90ipsc_promoter_p_PM_12_287_4			1	0.2	1.17E-04	DRAXIN, FCAR	commissural neuron differentiation in spinal cord [BP], IgA binding [MF]
CG_imr90ipsc_promoter_p_PM_12_455_12			2	0.4	2.40E-04	AMDHD2	N-acetylglucosamine-6-phosphate deacetylase activity [MF]
CG_imr90ipsc_promoter_p_PM_16_31_14			4	0.8	3.31E-05	GTSE1, POLD1, PSMB4	regulation of mitotic cell cycle [BP], DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [BP]
CG_imr90ipsc_promoter_p_PM_12_351_10			2	0.4	1.21E-05	LGALS1, SRD5A3	polyprenol catabolic process [BP], positive regulation of erythrocyte aggregation [BP]
CG_imr90ipsc_promoter_p_PM_12_231_7			2	0.4	7.25E-05	SLC13A2, RAD51, LEPROT	positive regulation of DNA ligation [BP], low affinity sodium:dicarboxylate symporter activity [MF], negative regulation of growth hormone receptor signaling pathway [BP]
CG_imr90ipsc_promoter_p_PM_12_281_8			2	0.4	1.19E-04	SLC7A2, PAM, PAPD4, ACTN3	protein amidation [BP], nuclear RNA-directed RNA polymerase complex [CC], focal adhesion assembly [BP], peptidylamidoglycolate lyase activity [MF], peptidylglycine monooxygenase activity [MF], high affinity arginine transmembrane transporter activity [MF]
CG_imr90ipsc_promoter_p_PM_12_346_9			2	0.4	9.11E-05	ST3GAL3	N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_197_4			2	0.4	3.59E-05	SPG7, NPEPPS	metalloendopeptidase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_283_8			2	0.4	6.25E-06	CHAT, MUC2, MAF1	establishment of synaptic specificity at neuromuscular junction [BP], RNA polymerase III type 2 promoter DNA binding [MF], rhythmic excitation [BP], negative regulation of transcription from RNA polymerase III promoter [BP], RNA polymerase III type 3 promoter DNA binding [MF], inner mucus layer [CC], choline O-acetyltransferase activity [MF], outer mucus layer [CC], RNA polymerase III type 1 promoter DNA binding [MF]
CG_imr90ipsc_promoter_p_PM_12_249_10			3	0.6	2.23E-04	CDKN1A	cyclin-dependent protein kinase activating kinase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_129_11			2	0.4	1.10E-04	NIPBL, CHAF1A, PARVB	establishment or maintenance of cell polarity regulating cell shape [BP], chromo shadow domain binding [MF]
CG_imr90ipsc_promoter_p_PM_12_37_11			4	0.6	7.24E-05	SLC5A7, NUDT2	choline:sodium symporter activity [MF], acetylcholine biosynthetic process [BP], bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity [MF], bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [MF]
CG_imr90ipsc_promoter_p_PM_12_292_18			4	0.6	2.51E-04	STAB1, ABP1, PCDHGA10, PCDHGA8, SSR4, COL6A2, PCDHGA7, MAVS	diamine oxidase activity [MF], histamine oxidase activity [MF], cellular response to azide [BP], cellular response to copper ion starvation [BP], positive regulation of IP-10 production [BP], cell adhesion [BP], homophilic cell adhesion [BP], calcium ion binding [MF], methylputrescine oxidase activity [MF], propane-1,3-diamine oxidase activity [MF], cell-cell adhesion [BP]
CG_imr90ipsc_promoter_p_PM_16_32_67			6	0.8	6.05E-05	HRH4, HTR6	histamine receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_6_10			3	0.6	1.19E-04	FSTL3	neuron projection terminus [CC]
CG_imr90ipsc_promoter_p_PM_12_92_7			2	0.4	3.93E-05	PPCS	phosphopantothenate--cysteine ligase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_353_16			5	0.8	2.05E-04	APOBEC3A, B3GALT6	clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine [BP], galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_432_6			2	0.4	1.31E-05	B4GALNT3	N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_328_11			2	0.4	3.48E-04	CHRNB2	lateral geniculate nucleus development [BP]
CG_imr90ipsc_promoter_p_PM_16_21_37			4	0.8	7.13E-05	LAMC1, PALM, ITGB4, PTEN	synapse maturation [BP], hemidesmosome assembly [BP]
CG_imr90ipsc_promoter_p_PM_12_40_13			1	0.2	1.96E-04	RAB25	pseudopodium membrane [CC]
CG_imr90ipsc_promoter_p_PM_12_54_6			2	0.4	4.27E-05	GRIA4	alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_254_9			2	0.4	4.54E-05	TICRR	G2/M transition checkpoint [BP]
CG_imr90ipsc_promoter_p_PM_12_84_17			2	0.4	5.62E-05	ACSF3, PARK7	positive regulation of oxidative phosphorylation uncoupler activity [BP], malonate catabolic process [BP], malonyl-CoA synthetase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_239_9			2	0.4	2.10E-04	AACS	acetoacetate-CoA ligase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_355_11			2	0.4	8.37E-05	P2RX2	detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [BP], drug binding [MF]
CG_imr90ipsc_promoter_p_PM_12_204_16			2	0.4	4.27E-05	HOXC13, TDGF1, MED12, FZD9	transcription cofactor activity [MF], canonical Wnt receptor signaling pathway [BP], anterior/posterior pattern specification [BP]
CG_imr90ipsc_promoter_p_PM_12_225_12			2	0.4	7.75E-05	DYSF, SCN2A	T-tubule [CC]
CG_imr90ipsc_promoter_p_PM_12_135_8			2	0.4	1.23E-04	ACADS, SLC30A8, PDX1	butyrate catabolic process [BP], positive regulation of insulin secretion [BP], butyryl-CoA dehydrogenase activity [MF]
CG_imr90ipsc_promoter_p_PM_16_26_19			4	0.8	7.35E-05	ENGASE	mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_56_6			3	0.6	2.67E-04	NLGN3, TRHR	regulation of long-term synaptic potentiation [BP], positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity [BP], regulation of terminal button organization [BP], thyrotropin-releasing hormone receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_123_24			2	0.4	1.88E-04	CD2, MYRF	positive regulation of myeloid dendritic cell activation [BP], central nervous system myelin maintenance [BP], membrane raft polarization [BP]
CG_imr90ipsc_promoter_p_PM_16_8_10			3	0.6	2.94E-05	PICK1, SQSTM1	protein kinase C binding [MF]
CG_imr90ipsc_promoter_p_PM_12_31_8			2	0.4	2.92E-04	IFNGR2, OAS3	interferon-gamma-mediated signaling pathway [BP], 2'-5'-oligoadenylate synthetase activity [MF], interferon-gamma receptor activity [MF], regulation of ribonuclease activity [BP]
CG_imr90ipsc_promoter_p_PM_12_75_9			3	0.6	4.91E-04	BPGM	phosphoglycerate mutase activity [MF], bisphosphoglycerate mutase activity [MF], bisphosphoglycerate 2-phosphatase activity [MF]
CG_imr90ipsc_promoter_p_PM_14_58_26			4	0.6	3.47E-05	CCND1, HHEX, NCOA4, WNT8A, GATA6	male gonad development [BP], liver development [BP], endoderm development [BP]
CG_imr90ipsc_promoter_p_PM_12_139_8			2	0.4	2.08E-04	BMPR1B, CEL, SMOC2	protein esterification [BP], heparin binding [MF], ovarian cumulus expansion [BP], sterol esterase activity [MF], intestinal lipid catabolic process [BP]
CG_imr90ipsc_promoter_p_PM_14_55_8			1	0.2	2.24E-05	GMPS	GMP synthase (glutamine-hydrolyzing) activity [MF], GMP synthase activity [MF]
CG_imr90ipsc_promoter_p_PM_16_44_9			3	0.6	3.11E-05	PLEK, BDKRB2	protein kinase C signaling cascade [BP], regulation of vascular permeability [BP]
CG_imr90ipsc_promoter_p_PM_16_50_36			5	1.0	9.46E-05	GATC, SAT1	regulation of translational fidelity [BP], spermidine binding [MF], diamine N-acetyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_237_9			2	0.4	1.48E-04	REST, ADSL	N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [MF], negative regulation of dense core granule biogenesis [BP], negative regulation of amniotic stem cell differentiation [BP], (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [MF], negative regulation of mesenchymal stem cell differentiation [BP]
CG_imr90ipsc_promoter_p_PM_12_415_16			2	0.4	2.29E-04	PML	negative regulation of translation in response to oxidative stress [BP], extrinsic to endoplasmic reticulum membrane [CC]
CG_imr90ipsc_promoter_p_PM_12_260_7			2	0.4	3.61E-05	EIF5A	annulate lamellae [CC]
CG_imr90ipsc_promoter_p_PM_16_35_18			2	0.4	5.37E-05	CRHR1, PPARA	negative regulation of appetite [BP]
CG_imr90ipsc_promoter_p_PM_16_19_28			2	0.4	6.62E-05	NDFIP1, MSH6, IFNL1	negative regulation of DNA recombination [BP], negative regulation of type 2 immune response [BP]
CG_imr90ipsc_promoter_p_PM_14_40_12			2	0.4	5.62E-05	CIRBP, KLK2, RBM3, CLIC4, MMP14	response to cold [BP], branching morphogenesis of an epithelial tube [BP], extracellular matrix disassembly [BP]
CG_imr90ipsc_promoter_p_PM_14_54_30			3	0.6	6.02E-05	CHMP7, CX3CL1	positive regulation of calcium-independent cell-cell adhesion [BP], late endosome to vacuole transport [BP]
CG_imr90ipsc_promoter_p_PM_12_389_8			4	0.8	3.97E-05	OTOGL	alpha-N-arabinofuranosidase activity [MF], L-arabinose metabolic process [BP]
CG_imr90ipsc_promoter_p_PM_12_144_12			1	0.2	4.33E-05	CABIN1, RNF32	aggresome [CC]
CG_imr90ipsc_promoter_p_PM_12_259_5			1	0.2	1.88E-04	IL13RA1	interleukin-13 receptor complex [CC]
CG_imr90ipsc_promoter_p_PM_16_24_12			2	0.4	1.16E-04	RAB25, PDGFRA	platelet-derived growth factor receptor-alpha signaling pathway [BP], positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [BP], platelet-derived growth factor alpha-receptor activity [MF], pseudopodium membrane [CC], vascular endothelial growth factor binding [MF], metanephric glomerular capillary formation [BP]
CG_imr90ipsc_promoter_p_PM_12_414_17			2	0.4	8.28E-05	RAB7A, RRM2, IQGAP1, UPB1	nucleobase-containing small molecule metabolic process [BP], Rac GTPase binding [MF]
CG_imr90ipsc_promoter_p_PM_12_434_7			2	0.4	3.20E-04	IVD, NADSYN1, STUB1	isovaleryl-CoA dehydrogenase activity [MF], NAD+ synthase (glutamine-hydrolyzing) activity [MF], positive regulation of chaperone-mediated protein complex assembly [BP]
CG_imr90ipsc_promoter_p_PM_12_227_10			3	0.6	7.49E-05	ASL	arginine biosynthetic process via ornithine [BP], argininosuccinate lyase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_310_8			3	0.4	1.29E-04	COG3, KIF19, TRAPPC2L	plus-end specific microtubule depolymerization [BP], ER to Golgi vesicle-mediated transport [BP], axonemal microtubule depolymerization [BP]
CG_imr90ipsc_promoter_p_PM_12_178_7			2	0.4	6.38E-05	CDK14, GPT	L-alanine:2-oxoglutarate aminotransferase activity [MF], cytoplasmic cyclin-dependent protein kinase holoenzyme complex [CC]
CG_imr90ipsc_promoter_p_PM_12_279_13			2	0.4	3.17E-05	CHST7, SAMM50, SIVA1	CD27 receptor binding [MF], mitochondrial sorting and assembly machinery complex [CC], chondroitin 6-sulfotransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_316_6			1	0.2	2.90E-05	SMAD3, CD86	positive regulation of lymphotoxin A biosynthetic process [BP], positive regulation of transforming growth factor beta3 production [BP]
CG_imr90ipsc_promoter_p_PM_12_393_13			2	0.4	1.70E-04	GSG2, MIOX, AACS, GRIN1, ACADM, AMD1, IFT43	histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [BP], medium-chain fatty acid catabolic process [BP], intraflagellar retrograde transport [BP], acetoacetate-CoA ligase activity [MF], histone kinase activity (H3-T3 specific) [MF], adenosylmethionine decarboxylase activity [MF], S-adenosylmethioninamine biosynthetic process [BP], propylene metabolic process [BP], inositol oxygenase activity [MF], inositol catabolic process [BP]
CG_imr90ipsc_promoter_p_PM_12_385_5			1	0.2	2.80E-04	MPST	thiosulfate sulfurtransferase activity [MF], 3-mercaptopyruvate sulfurtransferase activity [MF], cyanate catabolic process [BP]
CG_imr90ipsc_promoter_p_PM_12_222_9			2	0.4	2.08E-04	CHIA, MYC	cell wall chitin metabolic process [BP], negative regulation of G2 phase of mitotic cell cycle [BP], positive regulation of metanephric cap mesenchymal cell proliferation [BP]
CG_imr90ipsc_promoter_p_PM_12_82_15			2	0.4	7.38E-05	NT5E	adenosine biosynthetic process [BP]
CG_imr90ipsc_promoter_p_PM_12_387_8			2	0.4	1.09E-04	SLC5A2	low-affinity glucose:sodium symporter activity [MF]
CG_imr90ipsc_promoter_p_PM_12_381_6			2	0.4	1.60E-05	DDX20, ZNF473	Cajal body [CC]
CG_imr90ipsc_promoter_p_PM_12_110_14			2	0.4	2.03E-04	TFAP2B, GIPR	cellular urea homeostasis [BP], gastric inhibitory peptide receptor activity [MF], cellular creatinine homeostasis [BP], cellular ammonia homeostasis [BP]
CG_imr90ipsc_promoter_p_PM_16_37_15			1	0.2	5.45E-05	KHDRBS1	Grb2-Sos complex [CC]
CG_imr90ipsc_promoter_p_PM_12_268_16			4	0.6	1.15E-04	MPHOSPH8, SPIN1, SLC27A2, SYK	phytanate-CoA ligase activity [MF], pristanate-CoA ligase activity [MF], methylated histone residue binding [MF], cellular response to molecule of fungal origin [BP]
CG_imr90ipsc_promoter_p_PM_12_386_12			1	0.2	7.65E-05	PTBP1	negative regulation of muscle cell differentiation [BP]
CG_imr90ipsc_promoter_p_PM_12_38_6			3	0.6	8.31E-05	MYO6, IL12A, ATP2A2, IL1RN	interleukin-1 Type II receptor antagonist activity [MF], interleukin-1 Type I receptor antagonist activity [MF], calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF], minus-end directed microfilament motor activity [MF], interleukin-12 beta subunit binding [MF], glutamate secretion [BP], interleukin-27 binding [MF]
CG_imr90ipsc_promoter_p_PM_12_318_9			1	0.2	1.40E-04	IL1RN	interleukin-1 Type II receptor antagonist activity [MF], interleukin-1 Type I receptor antagonist activity [MF]
CG_imr90ipsc_promoter_p_PM_14_80_11			1	0.2	4.12E-05	ACER3, JMY, XPOT, PCYOX1	chloride-transporting ATPase activity [MF], phytosphingosine biosynthetic process [BP], 'de novo' actin filament nucleation [BP], tRNA export from nucleus [BP], phytoceramidase activity [MF], prenylcysteine oxidase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_374_9			3	0.6	9.69E-06	FAM20C	odontoblast differentiation [BP], dentinogenesis [BP], osteoclast maturation [BP]
CG_imr90ipsc_promoter_p_PM_12_34_7			1	0.2	7.30E-05	INPP1, OCRL	phosphatidylinositol phosphorylation [BP], inositol phosphate phosphatase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_19_3			1	0.2	3.49E-05	UGP2, B3GNT5	beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [MF], lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [MF], lipopolysaccharide N-acetylglucosaminyltransferase activity [MF], UTP:glucose-1-phosphate uridylyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_14_73_11			2	0.4	4.65E-05	RBBP6, MPHOSPH10	chromosome [CC]
CG_imr90ipsc_promoter_p_PM_12_300_16			2	0.4	3.14E-05	PRPF31, MARCH6, TBL1X, UBE2E2, MIER1	transcriptional repressor complex [CC], U4 snRNP [CC], snRNP binding [MF], protein K48-linked ubiquitination [BP], U4atac snRNP [CC]
CG_imr90ipsc_promoter_p_PM_14_91_7			2	0.4	1.11E-04	ALOX12, MAVS	hepoxilin-epoxide hydrolase activity [MF], positive regulation of IP-10 production [BP]
CG_imr90ipsc_promoter_p_PM_12_264_9			1	0.2	2.16E-04	SC5DL	cholesterol biosynthetic process via lathosterol [BP], C-5 sterol desaturase activity [MF], lathosterol oxidase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_161_10			2	0.4	1.24E-04	RRAGB, ZFPM1, ACR, GOLGA6D, GOLGA6B, EPHX2	4-nitrophenylphosphatase activity [MF], 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [MF], stilbene catabolic process [BP], acrosome matrix dispersal [BP], Golgi apparatus [CC], negative regulation of mast cell differentiation [BP], negative regulation of interleukin-4 biosynthetic process [BP], amidase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_16_10			3	0.6	8.91E-05	USP11, SENP3, IFRD1, PNLIPRP2, ATG4B	cysteine-type peptidase activity [MF], galactolipase activity [MF], ubiquitin-specific protease activity [MF], adult somatic muscle development [BP]
CG_imr90ipsc_promoter_p_PM_12_445_12			1	0.2	1.68E-04	ZAP70, IL27RA	interleukin-27 receptor activity [MF], B cell activation [BP], beta selection [BP], T cell aggregation [BP]
CG_imr90ipsc_promoter_p_PM_12_215_13			2	0.4	1.32E-04	TMEM187, COL6A2, ACADS	butyrate catabolic process [BP], transport vesicle [CC]
CG_imr90ipsc_promoter_p_PM_14_31_11			4	0.8	5.88E-05	RBM4	IRES-dependent translational initiation [BP], cap-independent translational initiation [BP], pre-mRNA intronic pyrimidine-rich binding [MF], circadian regulation of translation [BP]
CG_imr90ipsc_promoter_p_PM_12_375_11			4	0.6	1.78E-04	KIF3B	plus-end kinesin complex [CC]
CG_imr90ipsc_promoter_p_PM_12_10_6			2	0.4	2.99E-04	ZNF700, ZNF233, C8orf40, ZNF623, GLI4, ZNF586, ZKSCAN8, TEAD1, BAIAP2, ZNF549, ZNF763, ZNF793	transcription, DNA-dependent [BP], DNA binding [MF], zinc ion binding [MF], nucleus [CC]
CG_imr90ipsc_promoter_p_PM_12_63_13			3	0.6	5.93E-05	COLGALT1, ALG1	lipopolysaccharide biosynthetic process [BP]
CG_imr90ipsc_promoter_p_PM_12_271_14			2	0.4	8.57E-05	MUSK	positive regulation of protein geranylgeranylation [BP]
CG_imr90ipsc_promoter_p_PM_12_12_6			3	0.6	1.50E-04	PTGR2	15-oxoprostaglandin 13-oxidase activity [MF], 13-prostaglandin reductase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_457_7			2	0.4	2.20E-04	F2, FGFR3, API5	negative regulation of astrocyte differentiation [BP], fibroblast growth factor binding [MF]
CG_imr90ipsc_promoter_p_PM_12_331_8			3	0.6	2.07E-04	CSNK1G2, TUBB3, PAOX	N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF], N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF], spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [MF], peptide binding [MF], positive regulation of spermidine biosynthetic process [BP], N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF]
CG_imr90ipsc_promoter_p_PM_14_36_14			3	0.6	4.56E-05	TTC19, NEK6, ESPL1, RAB11A	cytokinesis [BP]
CG_imr90ipsc_promoter_p_PM_14_74_13			2	0.4	3.21E-05	SLC38A3, MPV17L, DGAT2, CARM1, NR2E1, IVD	asparagine transport [BP], amygdala development [BP], isovaleryl-CoA dehydrogenase activity [MF], histone methyltransferase activity (H3-R17 specific) [MF], negative regulation of hydrogen peroxide biosynthetic process [BP], histidine transport [BP], histone H3-R17 methylation [BP], cellular response to oleic acid [BP]
CG_imr90ipsc_promoter_p_PM_12_341_8			2	0.4	1.08E-04	MVK, MTRR, ANXA1	isopentenyl diphosphate biosynthetic process, mevalonate pathway [BP], mevalonate kinase activity [MF], neutrophil clearance [BP], [methionine synthase] reductase activity [MF], negative regulation of inflammatory response [BP], positive regulation of neutrophil apoptotic process [BP]
CG_imr90ipsc_promoter_p_PM_12_284_8			2	0.4	5.03E-05	SCP2	long-chain fatty acyl-CoA binding [MF], positive regulation of intracellular cholesterol transport [BP], oleic acid binding [MF], propanoyl-CoA C-acyltransferase activity [MF], lipid hydroperoxide transport [BP]
CG_imr90ipsc_promoter_p_PM_12_437_6			3	0.6	2.19E-04	NLGN3, CD2, ABP1	positive regulation of myeloid dendritic cell activation [BP], regulation of long-term synaptic potentiation [BP], diamine oxidase activity [MF], histamine oxidase activity [MF], cellular response to azide [BP], cellular response to copper ion starvation [BP], positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity [BP], regulation of terminal button organization [BP], receptor activity [MF], methylputrescine oxidase activity [MF], propane-1,3-diamine oxidase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_474_4			1	0.2	1.45E-04	CAV2, MYRIP, RASL10B, COL3A1	transport vesicle [CC], regulation of systemic arterial blood pressure by atrial natriuretic peptide [BP], positive regulation of peptide hormone secretion [BP], collagen type III [CC]
CG_imr90ipsc_promoter_p_PM_14_44_10			1	0.2	5.24E-05	FEM1A, DKK1, CCDC103	positive regulation of heart induction by negative regulation of canonical Wnt receptor signaling pathway [BP], inner dynein arm assembly [BP], negative regulation of cardiac muscle cell differentiation [BP], outer dynein arm assembly [BP], negative regulation of canonical Wnt receptor signaling pathway involved in cardiac muscle cell fate commitment [BP], EP4 subtype prostaglandin E2 receptor binding [MF]
CG_imr90ipsc_promoter_p_PM_12_61_10			2	0.4	6.79E-05	MOV10L1, NCK1, EIF3B, CASC3, AACS, SOX2, P2RX2, CDC5L	RNA binding [MF], regulation of translation [BP], protein complex scaffold [MF], detection of mechanical stimulus involved in equilibrioception [BP], acetoacetate-CoA ligase activity [MF], detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [BP], positive regulation of actin filament polymerization [BP]
CG_imr90ipsc_promoter_p_PM_12_277_11			2	0.4	4.42E-05	ARRB2	alpha-1A adrenergic receptor binding [MF], follicle-stimulating hormone receptor binding [MF], type 2A serotonin receptor binding [MF]
CG_imr90ipsc_promoter_p_PM_14_8_12			2	0.4	8.82E-05	HMOX1	cellular response to nutrient [BP]
CG_imr90ipsc_promoter_p_PM_12_433_6			1	0.2	9.53E-05	MIXL1	positive regulation of mesoderm development [BP]
CG_imr90ipsc_promoter_p_PM_16_3_9			3	0.6	3.00E-05	PNPO, DOLPP1	dolichyl diphosphate biosynthetic process [BP], vitamin B6 metabolic process [BP], dolichyldiphosphatase activity [MF], pyridoxine biosynthetic process [BP], pyridoxamine-phosphate oxidase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_262_12			2	0.4	1.07E-04	ILF3, D2HGDH, LRRFIP1, TLR4, ACER3	positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [BP], detection of fungus [BP], phytosphingosine biosynthetic process [BP], double-stranded RNA binding [MF], phytoceramidase activity [MF], positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [BP], (R)-2-hydroxyglutarate dehydrogenase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_132_13			3	0.6	2.13E-04	ACR	acrosome matrix dispersal [BP], amidase activity [MF]
CG_imr90ipsc_promoter_p_PM_16_43_15			2	0.4	1.02E-04	LLGL1, RPA1, APPL1, ATP11A, ACTR5, XRCC6, SNX1	early endosome [CC], double-strand break repair [BP], early endosome membrane [CC]
CG_imr90ipsc_promoter_p_PM_12_410_15			2	0.4	4.08E-05	PPARA, CARKD	regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter [BP], ATP-dependent NAD(P)H-hydrate dehydratase activity [MF], regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter [BP]
CG_imr90ipsc_promoter_p_PM_12_55_10			3	0.6	7.23E-05	EGR1, TIMP1, OS9	Hrd1p ubiquitin ligase complex [CC], response to carbon monoxide [BP], response to norepinephrine stimulus [BP], positive regulation of glomerular metanephric mesangial cell proliferation [BP], negative regulation of trophoblast cell migration [BP], cellular response to mycophenolic acid [BP], cellular response to isoquinoline alkaloid [BP]
CG_imr90ipsc_promoter_p_PM_12_68_10			3	0.6	4.20E-05	RNF5, ST3GAL3	N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF], ER-associated misfolded protein catabolic process [BP]
CG_imr90ipsc_promoter_p_PM_12_418_13			2	0.4	2.92E-05	PEX26, SLC25A4, PAOX	N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF], N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF], N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF], peroxisome [CC], spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [MF], spermine:oxygen oxidoreductase (spermidine-forming) activity [MF], positive regulation of spermidine biosynthetic process [BP], polyamine oxidase activity [MF], spermine catabolic process [BP], adenine transmembrane transporter activity [MF], spermidine catabolic process [BP]
CG_imr90ipsc_promoter_p_PM_14_17_16			3	0.6	6.67E-05	RCOR1, KIF3B, CD177, DNALI1, EXOC6	blood coagulation [BP], erythrocyte differentiation [BP], plus-end kinesin complex [CC], microtubule motor activity [MF]
CG_imr90ipsc_promoter_p_PM_14_20_12			2	0.4	2.64E-05	NIPBL	SMC loading complex [CC], external genitalia morphogenesis [BP]
CG_imr90ipsc_promoter_p_PM_16_13_20			3	0.6	6.11E-05	NOP58, VRTN, FDFT1	snRNP protein import into nucleus [BP], farnesyl-diphosphate farnesyltransferase activity [MF], squalene synthase activity [MF], transposition, DNA-mediated [BP]
CG_imr90ipsc_promoter_p_PM_12_459_20			3	0.6	1.89E-05	AMY2B, CNOT6	alpha-amylase activity [MF], positive regulation of ligand-dependent nuclear receptor transcription coactivator activity [BP]
CG_imr90ipsc_promoter_p_PM_12_67_12			2	0.4	9.00E-05	LEP, NNT, KIF23, HMGA1, SHBG	mitotic spindle elongation [BP], NAD(P)+ transhydrogenase (B-specific) activity [MF], positive regulation of hepatic stellate cell activation [BP], cellular response to L-ascorbic acid [BP], NAD(P)+ transhydrogenase (AB-specific) activity [MF], regulation of lipoprotein lipid oxidation [BP], positive regulation of luteinizing hormone secretion [BP], negative regulation of glutamine transport [BP], oncogene-induced senescence [BP], primary spermatocyte growth [BP]
CG_imr90ipsc_promoter_p_PM_12_275_13			1	0.2	1.24E-04	CDH15, ADRB1	beta1-adrenergic receptor activity [MF], positive regulation of muscle cell differentiation [BP], positive regulation of the force of heart contraction by norepinephrine [BP], positive regulation of cell growth involved in cardiac muscle cell development [BP]
CG_imr90ipsc_promoter_p_PM_12_439_8			2	0.4	3.79E-05	MDFIC, MAPK8IP3, NSD1	activation of JUN kinase activity [BP], histone methylation [BP]
CG_imr90ipsc_promoter_p_PM_12_103_10			4	0.6	5.46E-05	FGF5, FGF9, FEM1A, NUDT1	positive regulation of cell division [BP], fibroblast growth factor receptor binding [MF], EP4 subtype prostaglandin E2 receptor binding [MF], ATP diphosphatase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_125_10			3	0.6	4.11E-04	DIO3	thyroxine 5-deiodinase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_431_20			1	0.2	1.53E-04	FTO	regulation of lipid storage [BP]
CG_imr90ipsc_promoter_p_PM_14_66_15			2	0.4	1.45E-04	CACNG6	voltage-gated calcium channel complex [CC]
CG_imr90ipsc_promoter_p_PM_12_388_8			3	0.6	2.50E-04	THG1L	tRNA guanylyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_14_16_32			4	0.6	4.83E-05	EPHX1	cis-stilbene-oxide hydrolase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_134_18			1	0.2	1.22E-04	CSE1L	importin-alpha export receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_45_6			3	0.6	2.07E-05	ZMIZ1, MYOCD, GAPDH, USP20, USP8	peptidyl-cysteine S-nitrosylase activity [MF], peptidyl-cysteine S-trans-nitrosylation [BP], positive regulation of cardiac vascular smooth muscle cell differentiation [BP], glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [MF], protein K48-linked deubiquitination [BP], cysteine-type endopeptidase activity [MF], vasculogenesis [BP], artery morphogenesis [BP], vitellogenesis [BP], positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [BP], protein deubiquitination [BP], protein K63-linked deubiquitination [BP], ubiquitin thiolesterase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_329_13			2	0.4	1.17E-04	GLI2, JAM3, PMM2	mannose biosynthetic process [BP], spinal cord ventral commissure morphogenesis [BP], smoothened signaling pathway involved in ventral spinal cord interneuron specification [BP], notochord regression [BP], paranodal junction [CC], smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [BP], regulation of actin cytoskeleton organization by cell-cell adhesion [BP], phosphomannomutase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_127_6			2	0.4	1.46E-04	SDCBP, CAD, VIL1	cytoplasmic actin-based contraction involved in cell motility [BP], aspartate binding [MF], lysophosphatidic acid binding [MF], aspartate carbamoyltransferase activity [MF], interleukin-5 receptor complex [CC], carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [MF], cellular response to epidermal growth factor stimulus [BP], dihydroorotase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_106_8			2	0.4	1.43E-04	NAT8L, SHROOM2	eye pigment granule organization [BP], aspartate N-acetyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_360_17			3	0.4	2.50E-04	FXN	regulation of ferrochelatase activity [BP], proprioception [BP], iron incorporation into metallo-sulfur cluster [BP], iron chaperone activity [MF]
CG_imr90ipsc_promoter_p_PM_12_109_12			2	0.4	5.56E-05	NEUROD4, SLC13A2	low affinity sodium:dicarboxylate symporter activity [MF], amacrine cell differentiation [BP]
CG_imr90ipsc_promoter_p_PM_12_104_6			2	0.4	1.47E-04	EGR1, FKBP1B, SLC24A3, SLC13A2	low affinity sodium:dicarboxylate symporter activity [MF], negative regulation of release of sequestered calcium ion into cytosol [BP], positive regulation of sequestering of calcium ion [BP], response to norepinephrine stimulus [BP], calcium, potassium:sodium antiporter activity [MF], positive regulation of glomerular metanephric mesangial cell proliferation [BP], cellular response to mycophenolic acid [BP], cellular response to isoquinoline alkaloid [BP]
CG_imr90ipsc_promoter_p_PM_12_417_9			2	0.4	3.54E-05	PRKCZ, BCL3, PRLH	Bcl3-Bcl10 complex [CC], positive regulation of interleukin-13 secretion [BP], prolactin-releasing peptide receptor binding [MF], T-helper 2 cell differentiation [BP], reduction of food intake in response to dietary excess [BP], positive regulation of interleukin-10 biosynthetic process [BP], follicular dendritic cell differentiation [BP], positive regulation of interleukin-5 secretion [BP], marginal zone B cell differentiation [BP], Bcl3/NF-kappaB2 complex [CC]
CG_imr90ipsc_promoter_p_PM_14_28_23			2	0.4	1.17E-04	VRK1	Golgi disassembly [BP]
CG_imr90ipsc_promoter_p_PM_12_425_7			1	0.2	8.86E-05	RCN1, MKL2, NLRP5	in utero embryonic development [BP]
CG_imr90ipsc_promoter_p_PM_12_413_6			3	0.6	6.13E-05	GNAS	post-embryonic body morphogenesis [BP]
CG_imr90ipsc_promoter_p_PM_12_79_5			3	0.6	3.13E-04	SSR4, TGFBR2	positive regulation of tolerance induction to self antigen [BP], bronchus morphogenesis [BP], Sec61 translocon complex [CC], type III transforming growth factor beta receptor binding [MF], transforming growth factor beta receptor activity, type II [MF], positive regulation of B cell tolerance induction [BP]
CG_imr90ipsc_promoter_p_PM_12_224_9			1	0.2	9.30E-05	PSEN1, PRMT7, PAN3	[myelin basic protein]-arginine N-methyltransferase activity [MF], Cajal-Retzius cell differentiation [BP], positive regulation of cytoplasmic mRNA processing body assembly [BP]
CG_imr90ipsc_promoter_p_PM_14_63_8			2	0.4	3.61E-05	WNT1, RAD23B, CDH1	lateral loop [CC], XPC complex [CC], diencephalon development [BP], negative regulation of cell-cell adhesion [BP], canonical Wnt receptor signaling pathway involved in negative regulation of apoptotic process [BP], nucleotide-excision repair, DNA damage recognition [BP], central nervous system morphogenesis [BP], midbrain-hindbrain boundary maturation during brain development [BP], negative regulation of DNA damage checkpoint [BP], cerebellum formation [BP]
CG_imr90ipsc_promoter_p_PM_14_29_4			3	0.6	9.23E-05	SPHK1, SERPING1, PINK1	negative regulation of complement activation, lectin pathway [BP], D-erythro-sphingosine kinase activity [MF], sphingoid catabolic process [BP], sphinganine kinase activity [MF], C3HC4-type RING finger domain binding [MF]
CG_imr90ipsc_promoter_p_PM_12_366_11			2	0.4	1.12E-04	NADSYN1	NAD+ synthase (glutamine-hydrolyzing) activity [MF]
CG_imr90ipsc_promoter_p_PM_12_358_13			3	0.6	2.00E-04	CRELD1, PANX1, CHRD, FZD1	negative regulation of BMP signaling pathway [BP], cardiac septum development [BP], leak channel activity [MF], BMP signaling pathway involved in spinal cord dorsal/ventral patterning [BP]
CG_imr90ipsc_promoter_p_PM_12_143_9			1	0.2	1.58E-04	NSDHL, RGS14	nuclear body [CC], sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [MF]
CG_imr90ipsc_promoter_p_PM_12_138_10			2	0.4	6.02E-05	RSPH9, CCDC105, UPP1, TPGS1	cilium axoneme [CC], microtubule cytoskeleton organization [BP], uridine phosphorylase activity [MF]
CG_imr90ipsc_promoter_p_PM_14_82_32			3	0.4	4.72E-05	BBS4, CDC20, SAC3D1	centrosome [CC], centrosome organization [BP], positive regulation of flagellum assembly [BP]
CG_imr90ipsc_promoter_p_PM_14_57_11			3	0.6	5.43E-05	STRA8, SAT1	spermidine binding [MF], meiotic cell cycle DNA replication checkpoint [BP]
CG_imr90ipsc_promoter_p_PM_16_48_30			4	0.8	1.78E-04	ADO, CCDC64	cysteamine dioxygenase activity [MF], Golgi to secretory granule transport [BP]
CG_imr90ipsc_promoter_p_PM_12_199_17			3	0.6	4.09E-05	F10, GP9, SETDB1, FZD9	embryo development [BP], histone-lysine N-methyltransferase activity [MF], blood coagulation, intrinsic pathway [BP]
CG_imr90ipsc_promoter_p_PM_12_72_13			2	0.4	1.02E-04	WNK1, NCKAP1L, AKR1D1	delta4-3-oxosteroid 5beta-reductase activity [MF], negative regulation of myosin-light-chain-phosphatase activity [BP], positive regulation of CD8-positive, alpha-beta T cell differentiation [BP], actin polymerization-dependent cell motility [BP], negative regulation of phosphatase activity [BP], SCAR complex [CC]
CG_imr90ipsc_promoter_p_PM_12_121_14			2	0.4	2.05E-04	ELN, MET, NNMT, MVK, UGT1A1, BCAM	laminin receptor activity [MF], cytochrome complex [CC], nicotinamide N-methyltransferase activity [MF], organ regeneration [BP], extracellular matrix binding [MF], mevalonate kinase activity [MF], hepatocyte growth factor-activated receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_325_9			3	0.6	6.50E-05	SQRDL	sulfide:quinone oxidoreductase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_356_13			2	0.4	1.33E-04	EREG	primary follicle stage [BP], luteinizing hormone signaling pathway [BP]
CG_imr90ipsc_promoter_p_PM_12_465_10			1	0.2	1.62E-04	MARC2	nitrate reductase activity [MF], nitrate metabolic process [BP]
CG_imr90ipsc_promoter_p_PM_12_368_10			3	0.6	1.39E-04	GNAZ, P2RX4, TAF15, GNAT1	apical part of cell [CC], G-protein beta/gamma-subunit complex binding [MF], nucleotide binding [MF]
CG_imr90ipsc_promoter_p_PM_12_473_8			2	0.4	1.55E-04	RYR2, BRDT	histone displacement [BP], positive regulation of calcium-transporting ATPase activity [BP], positive regulation of transcription during meiosis [BP], positive regulation of sequestering of calcium ion [BP], intrinsic apoptotic signaling pathway in response to osmotic stress [BP], Purkinje myocyte to ventricular cardiac muscle cell signaling [BP], left ventricular cardiac muscle tissue morphogenesis [BP], positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor signaling pathway involved in positive regulation of cardiac muscle contraction [BP], suramin binding [MF], calcium-induced calcium release activity [MF]
CG_imr90ipsc_promoter_p_PM_12_165_13			2	0.4	5.30E-05	MRPL22, PNPLA3	mono-olein transacylation activity [MF], large ribosomal subunit [CC], diolein transacylation activity [MF]
CG_imr90ipsc_promoter_p_PM_12_305_21			2	0.4	2.31E-04	MANEA, MAPK8IP1	glycoprotein endo-alpha-1,2-mannosidase activity [MF], JUN phosphorylation [BP], dentate gyrus mossy fiber [CC], dendritic growth cone [CC]
CG_imr90ipsc_promoter_p_PM_12_252_14			2	0.4	2.71E-04	FOXC2, HES1	negative regulation of stomach neuroendocrine cell differentiation [BP], glomerular endothelium development [BP], lateral inhibition [BP], negative regulation of forebrain neuron differentiation [BP], negative regulation of auditory receptor cell differentiation [BP], negative regulation of pro-B cell differentiation [BP], trochlear nerve development [BP], neural crest cell development [BP], Notch signaling pathway [BP], ascending aorta morphogenesis [BP], artery morphogenesis [BP], common bile duct development [BP], auditory receptor cell fate determination [BP], renal interstitial cell development [BP], positive regulation of mitotic cell cycle, embryonic [BP], ureteric bud development [BP], N-box binding [MF], negative regulation of pancreatic A cell differentiation [BP], positive regulation of vascular wound healing [BP], glomerulus vasculature development [BP], metanephros development [BP], embryonic heart tube development [BP]
CG_imr90ipsc_promoter_p_PM_12_29_8			2	0.4	3.91E-05	GATA1, CTNS	basophil differentiation [BP], compound eye corneal lens development [BP], eosinophil fate commitment [BP], transcriptional activation by promoter-enhancer looping [BP]
CG_imr90ipsc_promoter_p_PM_12_422_11			2	0.4	1.33E-04	CHRNB2	lateral geniculate nucleus development [BP]
CG_imr90ipsc_promoter_p_PM_12_350_16			2	0.4	1.27E-04	DNAH1, TPGS1	cilium axoneme [CC]
CG_imr90ipsc_promoter_p_PM_12_90_13			2	0.4	3.05E-05	ECT2, CRYAA, DNM2	midbody [CC], response to hydrogen peroxide [BP], M phase specific microtubule process [BP]
CG_imr90ipsc_promoter_p_PM_12_167_5			2	0.4	2.37E-04	BMPR1A, MDFI	paraxial mesoderm structural organization [BP], dorsal/ventral axis specification [BP], neural plate mediolateral regionalization [BP]
CG_imr90ipsc_promoter_p_PM_12_301_5			2	0.4	7.77E-06	PRKCB, EIF2S1, MRPS18C, FMR1	polysome [CC], eukaryotic translation initiation factor 2 complex [CC], histone kinase activity (H3-T6 specific) [MF], histone H3-T6 phosphorylation [BP], cytoplasmic stress granule [CC], translation [BP], neuronal ribonucleoprotein granule [CC]
CG_imr90ipsc_promoter_p_PM_12_207_9			2	0.4	2.32E-04	KIF2C	establishment or maintenance of microtubule cytoskeleton polarity [BP]
CG_imr90ipsc_promoter_p_PM_12_426_10			2	0.4	6.52E-05	AMY2B	alpha-amylase activity [MF]
CG_imr90ipsc_promoter_p_PM_16_5_14			3	0.6	4.83E-05	MAT2A, ARG2	arginase activity [MF], methionine adenosyltransferase activity [MF], methanogenesis [BP]
CG_imr90ipsc_promoter_p_PM_12_327_14			3	0.6	3.36E-05	KIF3B, DRD4	plus-end kinesin complex [CC], kinesin II complex [CC], negative regulation of voltage-gated calcium channel activity [BP], olfactory learning [BP], dopamine neurotransmitter receptor activity, coupled via Gi/Go [MF]
CG_imr90ipsc_promoter_p_PM_12_248_10			3	0.6	3.80E-04	FBXO18, CHRD, G3BP1, LTBP4, ACVR2A	transmembrane receptor protein serine/threonine kinase signaling pathway [BP], ATP-dependent DNA helicase activity [MF], transmembrane receptor protein serine/threonine kinase activity [MF], transforming growth factor beta-activated receptor activity [MF], gastrulation with mouth forming second [BP]
CG_imr90ipsc_promoter_p_PM_12_96_10			2	0.4	2.02E-05	AGPS	alkylglycerone-phosphate synthase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_169_5			2	0.4	1.12E-04	STBD1	starch binding [MF]
CG_imr90ipsc_promoter_p_PM_14_86_9			2	0.4	3.90E-05	RYR3, CAPN3, IFNAR2	autolysis [BP], type I interferon binding [MF], cellular response to calcium ion [BP], ligase regulator activity [MF], G1 to G0 transition involved in cell differentiation [BP]
CG_imr90ipsc_promoter_p_PM_12_50_18			3	0.6	2.28E-05	TARS2	mitochondrial threonyl-tRNA aminoacylation [BP]
CG_imr90ipsc_promoter_p_PM_12_443_12			2	0.4	2.06E-05	DIS3L2	exonuclease activity [MF]
CG_imr90ipsc_promoter_p_PM_12_27_6			1	0.2	3.17E-05	FIG4	phosphatidylinositol-4-phosphate phosphatase activity [MF], phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_52_15			4	0.6	8.53E-05	CBR1, P2RX4, NUDT2	15-hydroxyprostaglandin dehydrogenase (NADP+) activity [MF], bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity [MF], regulation of cardiac muscle contraction [BP], bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [MF], prostaglandin-E2 9-reductase activity [MF]
CG_imr90ipsc_promoter_p_PM_16_12_30			5	1.0	4.56E-05	NEK6, APOBEC3H, SRSF3, LSM14B, APOBEC3G, RPS7, PIN1, WBP4, PAN3	cytidine deamination [BP], DNA cytosine deamination [BP], negative regulation of transposition [BP], nuclear speck [CC], negative regulation of retroviral genome replication [BP], cytoplasmic mRNA processing body [CC], cytidine deaminase activity [MF], ribonucleoprotein complex [CC]
CG_imr90ipsc_promoter_p_PM_14_76_6			3	0.6	2.40E-05	DAG1, PAFAH1B1	tubulin binding [MF], astral microtubule [CC], nerve maturation [BP], establishment of centrosome localization [BP]
CG_imr90ipsc_promoter_p_PM_14_13_20			5	0.8	3.27E-05	GATA3, OPRD1, CRYAA, SOX17	endodermal cell fate determination [BP], pro-T cell differentiation [BP], stem cell fate specification [BP], enkephalin receptor activity [MF], lens development in camera-type eye [BP], positive regulation of interleukin-13 secretion [BP], regulation of stem cell division [BP], negative regulation of cell proliferation involved in mesonephros development [BP], embryonic organ development [BP], cardiogenic plate morphogenesis [BP], cell fate determination [BP], M phase specific microtubule process [BP], regulation of embryonic development [BP], parathyroid hormone secretion [BP], negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP], regulation of cellular response to X-ray [BP], negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP], inner cell mass cellular morphogenesis [BP], positive regulation of interleukin-5 secretion [BP], regulation of histone H3-K27 methylation [BP], canonical Wnt receptor signaling pathway involved in metanephric kidney development [BP], regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification [BP]
CG_imr90ipsc_promoter_p_PM_12_57_12			2	0.4	1.19E-04	MCU, GTPBP4	negative regulation of collagen binding [BP], protein complex oligomerization [BP], uniporter activity [MF]
CG_imr90ipsc_promoter_p_PM_12_255_13			1	0.2	3.65E-04	SLC2A8, DIO1, RAC1, NTRK1, RAMP3, SSTR5, OR2F1, WBP4, GPR160, CD300A, IFI30, RASSF7, P2RX6, IFITM2	receptor activity [MF], positive regulation of Ras protein signal transduction [BP], plasma membrane [CC], signal transduction [BP]
CG_imr90ipsc_promoter_p_PM_12_420_12			3	0.6	3.05E-04	PCK1	glycerol biosynthetic process from pyruvate [BP]
CG_imr90ipsc_promoter_p_PM_12_201_9			2	0.4	1.04E-04	REEP2	taste receptor binding [MF]
CG_imr90ipsc_promoter_p_PM_12_361_22			2	0.4	6.12E-05	MIOX, EXOSC4, CNOT3	nuclear-transcribed mRNA poly(A) tail shortening [BP], nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [BP], oxidoreductase activity, acting on NAD(P)H [MF]
CG_imr90ipsc_promoter_p_PM_12_14_24			7	0.8	9.63E-05	AANAT, SNRPD1, LSM6	small nuclear ribonucleoprotein complex [CC], aralkylamine N-acetyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_16_7_13			4	0.8	4.12E-05	BMPR1B	ovarian cumulus expansion [BP]
CG_imr90ipsc_promoter_p_PM_12_308_13			3	0.6	3.41E-05	INSIG1	negative regulation of cargo loading into COPII-coated vesicle [BP]
CG_imr90ipsc_promoter_p_PM_12_295_9			2	0.4	1.66E-04	AP1M1, KANK1, LLGL1, POP1	maintenance of apical/basal cell polarity [BP], tRNA 5'-leader removal [BP], trans-Golgi network membrane [CC], negative regulation of lamellipodium morphogenesis [BP], ribonuclease MRP activity [MF], tRNA catabolic process [BP], negative regulation of ruffle assembly [BP], post-Golgi vesicle-mediated transport [BP]
CG_imr90ipsc_promoter_p_PM_12_299_9			2	0.4	2.98E-05	NOG, TCF7	negative regulation of cytokine activity [BP], embryonic hindgut morphogenesis [BP], regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], embryonic genitalia morphogenesis [BP], positive regulation of glomerulus development [BP], neural tube development [BP], canonical Wnt receptor signaling pathway [BP]
CG_imr90ipsc_promoter_p_PM_12_303_10			3	0.4	2.04E-04	LDLRAP1	receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport [BP], clathrin adaptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_367_9			3	0.6	7.29E-05	EGR1	oligodendrocyte differentiation [BP], positive regulation of glomerular metanephric mesangial cell proliferation [BP]
CG_imr90ipsc_promoter_p_PM_12_365_4			5	1.0	5.84E-05	PTK2B, POLR2A, XRCC4, MID1IP1, ERBB2	response to lithium ion [BP], RNA-directed RNA polymerase activity [MF], RNA polymerase I core binding [MF], 3-phosphoinositide-dependent protein kinase binding [MF], protein C-terminus binding [MF]
CG_imr90ipsc_promoter_p_PM_12_120_9			1	0.2	4.59E-04	MAML1	MAML1-RBP-Jkappa- ICN1 complex [CC], atrioventricular node cell development [BP], atrioventricular node development [BP]
CG_imr90ipsc_promoter_p_PM_12_156_5			1	0.2	1.04E-05	SRC	cellular response to progesterone stimulus [BP]
CG_imr90ipsc_promoter_p_PM_12_105_8			2	0.4	5.84E-05	DNHD1, BCAM	dynein complex [CC], laminin receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_344_9			1	0.2	2.09E-04	MARC1, TP73, AMH	molybdenum ion binding [MF], cerebrospinal fluid secretion [BP], nitrate metabolic process [BP], preantral ovarian follicle growth [BP], nitrate reductase activity [MF], gonadal mesoderm development [BP]
CG_imr90ipsc_promoter_p_PM_12_450_11			2	0.4	1.82E-05	SERPINE1, GPD1L	negative regulation of vascular wound healing [BP], positive regulation of leukotriene production involved in inflammatory response [BP], negative regulation of protein kinase C signaling cascade [BP]
CG_imr90ipsc_promoter_p_PM_12_352_7			1	0.2	1.37E-04	DGKD, BDKRB1	protein kinase C-activating G-protein coupled receptor signaling pathway [BP]
CG_imr90ipsc_promoter_p_PM_16_47_15			2	0.4	1.07E-04	TAS1R1	sensory perception of umami taste [BP]
CG_imr90ipsc_promoter_p_PM_12_145_13			2	0.4	9.36E-05	PKNOX1, FOXC1, CREB1	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_251_12			3	0.6	1.18E-04	ZGPAT, ARHGEF7, CBLC	negative regulation of epidermal growth factor receptor signaling pathway [BP], negative regulation of epidermal growth factor-activated receptor activity [BP]
CG_imr90ipsc_promoter_p_PM_16_30_34			4	0.8	8.90E-05	DNAJB2	negative regulation of inclusion body assembly [BP], negative regulation of protein deubiquitination [BP]
CG_imr90ipsc_promoter_p_PM_12_456_10			2	0.4	1.74E-04	LMNA, LDLRAP1, POLD1	receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport [BP], DNA replication proofreading [BP], sterol regulatory element binding protein import into nucleus [BP], clathrin adaptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_154_10			2	0.4	1.43E-05	PLEK, GSTP1	negative regulation of inositol phosphate biosynthetic process [BP], phospholipase C-inhibiting G-protein coupled receptor signaling pathway [BP], positive regulation of inositol-polyphosphate 5-phosphatase activity [BP], nitric oxide storage [BP], protein secretion by platelet [BP], TRAF2-GSTP1 complex [CC], regulation of cell diameter [BP], nitric oxide binding [MF], dinitrosyl-iron complex binding [MF], S-nitrosoglutathione binding [MF]
CG_imr90ipsc_promoter_p_PM_12_330_6			2	0.4	1.49E-04	ATCAY	negative regulation of glutamate metabolic process [BP]
CG_imr90ipsc_promoter_p_PM_14_23_13			4	0.8	2.15E-05	GRIN1, OMP, PAFAH1B1, SPAST, HAUS2	microtubule cytoskeleton organization [BP], establishment of centrosome localization [BP], spindle [CC], astral microtubule [CC], axon [CC], microtubule [CC], microtubule organizing center organization [BP], propylene metabolic process [BP]
CG_imr90ipsc_promoter_p_PM_14_51_21			10	1.0	6.45E-05	DRD4, NAT8L, TADA2A	regulation of tubulin deacetylation [BP], positive regulation of dopamine uptake involved in synaptic transmission [BP]
CG_imr90ipsc_promoter_p_PM_12_25_8			2	0.4	3.18E-05	DGUOK, ACSM5	deoxyguanosine kinase activity [MF], mitochondrial matrix [CC]
CG_imr90ipsc_promoter_p_PM_14_14_11			4	0.6	3.56E-05	NCMAP	peripheral nervous system myelin formation [BP], structural constituent of myelin sheath [MF]
CG_imr90ipsc_promoter_p_PM_12_404_9			2	0.4	7.82E-05	HTT	diazepam binding [MF]
CG_imr90ipsc_promoter_p_PM_12_291_8			2	0.4	4.71E-05	RSAD2, APOBEC3A	positive regulation of toll-like receptor 7 signaling pathway [BP], positive regulation of toll-like receptor 9 signaling pathway [BP], clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine [BP], negative regulation of viral genome replication [BP]
CG_imr90ipsc_promoter_p_PM_12_142_8			2	0.4	3.91E-05	TYMS	deoxyribonucleoside monophosphate biosynthetic process [BP], thymidylate synthase activity [MF], immortalization of host cell by virus [BP], dTMP biosynthetic process [BP]
CG_imr90ipsc_promoter_p_PM_12_189_8			2	0.4	1.86E-04	RIPK1	regulation of ATP:ADP antiporter activity [BP]
CG_imr90ipsc_promoter_p_PM_12_354_6			2	0.4	6.31E-05	CCL25, MSMB, FOLR2, ARTN, MSLN	anchored to membrane [CC], extracellular space [CC]
CG_imr90ipsc_promoter_p_PM_12_347_12			2	0.4	9.48E-05	ARHGEF10	positive regulation of GTP catabolic process [BP]
CG_imr90ipsc_promoter_p_PM_12_66_9			1	0.2	1.53E-04	HOGA1	oxalate metabolic process [BP], 4-hydroxy-2-oxoglutarate aldolase activity [MF]
CG_imr90ipsc_promoter_p_PM_14_53_37			10	1.0	5.97E-05	ATP2A1, KIF1B, RHOT1, RHOT2, CREBRF, DNM1L, MAVS, CDC42, NACC1	nuclear body [CC], organelle transport along microtubule [BP], apoptotic mitochondrial changes [BP], mitochondrion transport along microtubule [BP], regulation of peroxisome organization [BP], positive regulation of protein transport [BP]
CG_imr90ipsc_promoter_p_PM_14_90_15			4	0.6	8.25E-05	BMP1, MYCN	cartilage condensation [BP]
CG_imr90ipsc_promoter_p_PM_12_392_6			2	0.4	5.66E-05	HEXB, YY1, HAS3, PRMT1	snoRNP binding [MF], response to prostaglandin F stimulus [BP], male courtship behavior [BP], [cytochrome c]-arginine N-methyltransferase activity [MF], hyaluronan metabolic process [BP]
CG_imr90ipsc_promoter_p_PM_12_181_8			2	0.4	3.86E-05	VMA21	vacuolar proton-transporting V-type ATPase complex assembly [BP]
CG_imr90ipsc_promoter_p_PM_12_184_13			2	0.4	1.04E-04	FGFR1OP	negative regulation of protein tyrosine kinase activity [BP]
CG_imr90ipsc_promoter_p_PM_16_2_21			5	1.0	3.30E-05	ATP6V0E1	response to amino acid stimulus [BP]
CG_imr90ipsc_promoter_p_PM_12_209_18			2	0.4	8.98E-05	CACNA1E, TOM1L1, ZNRF2, CACNA1D	voltage-gated calcium channel activity [MF], voltage-gated calcium channel complex [CC], endosome membrane [CC]
CG_imr90ipsc_promoter_p_PM_12_188_10			1	0.2	1.04E-04	PPP1CB	myosin phosphatase activity [MF], myosin-light-chain-phosphatase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_26_7			2	0.4	8.25E-05	SQRDL, AASDHPPT, PAICS	phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [MF], sulfide:quinone oxidoreductase activity [MF], holo-[acyl-carrier-protein] synthase activity [MF], phosphoribosylaminoimidazole carboxylase activity [MF], 5-(carboxyamino)imidazole ribonucleotide mutase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_345_13			2	0.4	4.52E-05	LHX1	horizontal cell localization [BP], uterine epithelium development [BP], nephric duct elongation [BP], oviduct epithelium development [BP]
CG_imr90ipsc_promoter_p_PM_12_168_6			1	0.2	1.34E-05	SAMM50, CDH13	mitochondrial sorting and assembly machinery complex [CC], adiponectin binding [MF], low-density lipoprotein particle mediated signaling [BP]
CG_imr90ipsc_promoter_p_PM_12_267_10			2	0.4	1.20E-04	LIPC, SPATA18, TAC1	mitochondrion degradation by induced vacuole formation [BP], substance P receptor binding [MF], intermediate-density lipoprotein particle remodeling [BP]
CG_imr90ipsc_promoter_p_PM_16_40_17			5	1.0	6.26E-05	SRP9	signal recognition particle receptor complex [CC]
CG_imr90ipsc_promoter_p_PM_12_28_6			2	0.4	8.05E-05	LRRK2, MYLK2	peptidyl-threonine phosphorylation [BP], negative regulation of branching morphogenesis of a nerve [BP], GTP-dependent protein kinase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_13_17			2	0.4	1.14E-04	GJA1	vascular transport [BP]
CG_imr90ipsc_promoter_p_PM_14_75_10			3	0.4	3.07E-05	PPP2R5C, PPP2R1A	protein phosphatase type 2A regulator activity [MF], protein phosphatase type 2A complex [CC]
CG_imr90ipsc_promoter_p_PM_14_65_15			3	0.6	7.06E-05	MC1R, C1QTNF1, PTPRJ, AXL, RARA	positive regulation of protein kinase B signaling cascade [BP], negative regulation of tumor necrosis factor production [BP], protein kinase B signaling cascade [BP]
CG_imr90ipsc_promoter_p_PM_12_378_21			3	0.6	6.94E-05	RPA1, ERCC4	nucleotide-excision repair, DNA damage removal [BP]
CG_imr90ipsc_promoter_p_PM_12_406_10			3	0.6	1.05E-04	APPL1, HDAC1	NuRD complex [CC]
CG_imr90ipsc_promoter_p_PM_12_128_11			1	0.2	2.01E-04	HSPB1, KATNB1, CTNS, FOXC2, KIF20A, CDC16	positive regulation of blood vessel endothelial cell migration [BP], spindle [CC], katanin complex [CC], compound eye corneal lens development [BP], positive regulation of endothelial cell migration [BP], vascular endothelial growth factor receptor signaling pathway [BP]
CG_imr90ipsc_promoter_p_PM_12_193_11			2	0.4	3.11E-05	BCMO1, AASDHPPT, SMC2	beta-carotene 15,15'-monooxygenase activity [MF], vitamin metabolic process [BP], holo-[acyl-carrier-protein] synthase activity [MF], vitamin A biosynthetic process [BP], meiotic chromosome condensation [BP]
CG_imr90ipsc_promoter_p_PM_12_380_12			3	0.6	9.23E-05	ATF7IP	regulation of RNA polymerase II transcriptional preinitiation complex assembly [BP]
CG_imr90ipsc_promoter_p_PM_12_192_14			2	0.4	1.06E-04	TTYH3, STRA8, CLCA2	female meiosis sister chromatid cohesion [BP], chloride channel activity [MF], meiotic cell cycle DNA replication checkpoint [BP], meiotic DNA double-strand break formation [BP]
CG_imr90ipsc_promoter_p_PM_14_47_22			2	0.4	1.04E-05	DCLRE1B	telomeric 3' overhang formation [BP]
CG_imr90ipsc_promoter_p_PM_12_462_6			1	0.2	4.73E-05	SPR, ESR1, LBP	nitric oxide biosynthetic process [BP], positive regulation of respiratory burst involved in inflammatory response [BP], leukocyte chemotaxis involved in inflammatory response [BP], estrogen-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], sepiapterin reductase activity [MF], regulation of nitric-oxide synthase activity [BP]
CG_imr90ipsc_promoter_p_PM_12_321_11			2	0.4	7.36E-05	MARK2, TENM3	positive regulation of neuron projection development [BP]
CG_imr90ipsc_promoter_p_PM_12_261_11			1	0.2	2.67E-05	FAM103A1	recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex [BP]
CG_imr90ipsc_promoter_p_PM_16_16_9			4	0.8	7.65E-05	PPP1R8	ribonuclease E activity [MF]
CG_imr90ipsc_promoter_p_PM_12_306_7			2	0.4	3.09E-05	BMI1, WNT3A	rostrocaudal neural tube patterning [BP], positive regulation of B cell proliferation [BP], somatic stem cell division [BP]
CG_imr90ipsc_promoter_p_PM_12_48_11			2	0.4	2.02E-05	PRKCA, MYLK2, IDUA, PPCS, SLC1A4	L-hydroxyproline transmembrane transporter activity [MF], positive regulation of dense core granule biogenesis [BP], L-iduronidase activity [MF], phosphopantothenate--cysteine ligase activity [MF], peptidyl-threonine phosphorylation [BP], threonine transport [BP], L-threonine transmembrane transporter activity [MF], hydroxyproline transport [BP]
CG_imr90ipsc_promoter_p_PM_12_466_6			1	0.2	7.39E-06	ARHGEF16, CACNA1C	smooth muscle contraction involved in micturition [BP], caveolar macromolecular signaling complex [CC], activation of Cdc42 GTPase activity [BP], calcium-mediated signaling using extracellular calcium source [BP]
CG_imr90ipsc_promoter_p_PM_12_80_5			1	0.2	9.86E-05	PML, PLOD1, MGRN1, ZNF175, TLR2	early endosome [CC], hydroxylysine biosynthetic process [BP], extrinsic to endoplasmic reticulum membrane [CC], defense response to virus [BP], cell surface pattern recognition receptor signaling pathway [BP], induction by symbiont of defense-related host nitric oxide production [BP], negative regulation of translation in response to oxidative stress [BP], chloramphenicol transport [BP], triacyl lipopeptide binding [MF]
CG_imr90ipsc_promoter_p_PM_12_298_8			4	0.8	8.14E-05	SPR, RCC1, SAC3D1	sepiapterin reductase activity [MF], spindle assembly [BP]
CG_imr90ipsc_promoter_p_PM_12_133_15			2	0.4	1.44E-04	CA14, LIAS, ERBB2	lipoate synthase activity [MF], RNA polymerase I core binding [MF], lipoate biosynthetic process [BP], small molecule metabolic process [BP]
CG_imr90ipsc_promoter_p_PM_12_357_7			1	0.2	6.96E-05	LDHC	lactate oxidation [BP]
CG_imr90ipsc_promoter_p_PM_12_214_13			1	0.2	1.09E-04	DRAXIN, PGAM1, PARK7	positive regulation of oxidative phosphorylation uncoupler activity [BP], regulation of pentose-phosphate shunt [BP], commissural neuron differentiation in spinal cord [BP]
CG_imr90ipsc_promoter_p_PM_12_35_13			4	0.8	4.10E-05	SLC35A1	CMP-N-acetylneuraminate transport [BP], CMP-N-acetylneuraminate transmembrane transporter activity [MF]
CG_imr90ipsc_promoter_p_PM_12_47_7			2	0.4	7.32E-05	DCLRE1B	telomeric loop formation [BP], telomeric 3' overhang formation [BP]
CG_imr90ipsc_promoter_p_PM_14_2_32			12	1.0	4.58E-05	ACTN4, DRD4, ALMS1, PTCHD2, ACSM3, SOAT2	positive regulation of sodium:hydrogen antiporter activity [BP], cholesterol homeostasis [BP]
CG_imr90ipsc_promoter_p_PM_16_28_109			5	1.0	7.22E-05	SF3B2, NOM1, MATR3, ERAL1, EIF5A, SRSF5, SLIRP, RBM10, PCBP1, DDX19B, RNMTL1, MRM1, USP39, POLR2F, POLR2A, EIF4H, DDX25, RPL19, SNRPE, ZNF638, SNRPD1, RALY, RBM48, APOBEC3F, GEMIN7, UPF3A, SFSWAP, TLR8, HNRNPH3	RNA splicing [BP], RNA binding [MF], spliceosomal complex assembly [BP], mRNA splicing, via spliceosome [BP]
CG_imr90ipsc_promoter_p_PM_12_464_6			1	0.2	1.78E-04	HTT, CYP46A1	neural plate formation [BP], diazepam binding [MF], cholesterol 24-hydroxylase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_191_12			1	0.2	1.02E-04	CRHBP, OCIAD1	endosome [CC], hormone-mediated signaling pathway [BP]
CG_imr90ipsc_promoter_p_PM_12_219_12			3	0.6	7.63E-05	GP9, F2	blood coagulation, intrinsic pathway [BP]
CG_imr90ipsc_promoter_p_PM_16_49_25			1	0.2	1.73E-05	ASRGL1, EIF3K, RPL36	beta-aspartyl-peptidase activity [MF], asparagine catabolic process via L-aspartate [BP], translational initiation [BP], asparaginase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_148_9			3	0.6	9.53E-05	BCAM, ARHGAP5	Rho GTPase activator activity [MF], laminin receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_21_10			3	0.6	9.61E-05	MPV17L, STRA8	meiotic cell cycle DNA replication checkpoint [BP], negative regulation of hydrogen peroxide biosynthetic process [BP]
CG_imr90ipsc_promoter_p_PM_12_323_13			4	0.6	1.00E-04	LEP	cellular response to L-ascorbic acid [BP], negative regulation of glutamine transport [BP]
CG_imr90ipsc_promoter_p_PM_12_370_13			2	0.4	6.08E-05	GDPD2	glycerophosphoinositol inositolphosphodiesterase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_372_16			2	0.4	7.43E-05	ATP7A	copper ion export [BP], copper-dependent protein binding [MF], regulation of oxidative phosphorylation [BP], copper-exporting ATPase activity [MF], response to iron(III) ion [BP], elastin biosynthetic process [BP], negative regulation of metalloenzyme activity [BP], superoxide dismutase copper chaperone activity [MF], copper ion import [BP], epinephrine metabolic process [BP], detoxification of copper ion [BP]
CG_imr90ipsc_promoter_p_PM_14_83_20			3	0.6	4.11E-05	CORO1A, PTEN	negative regulation of cyclin-dependent protein kinase activity involved in G1/S [BP], postsynaptic density assembly [BP], negative regulation of actin nucleation [BP], negative regulation of ribosome biogenesis [BP], negative regulation of synaptic vesicle clustering [BP]
CG_imr90ipsc_promoter_p_PM_12_3_10			1	0.2	1.13E-04	PRLH, TRH	neuropeptide hormone activity [MF], eating behavior [BP]
CG_imr90ipsc_promoter_p_PM_12_60_11			3	0.6	7.57E-05	DPPA3	negative regulation of DNA demethylation [BP], protection of DNA demethylation of female pronucleus [BP]
CG_imr90ipsc_promoter_p_PM_12_8_11			2	0.4	3.14E-04	DNASE1, NR1H2, PTPRO	positive regulation of secretion of lysosomal enzymes [BP], deoxyribonuclease I activity [MF], positive regulation of pancreatic juice secretion [BP], positive regulation of high-density lipoprotein particle assembly [BP], negative regulation of retinal ganglion cell axon guidance [BP], negative regulation of pinocytosis [BP], slit diaphragm assembly [BP], sequence-specific transcription regulatory region DNA binding RNA polymerase II transcription factor recruiting transcription factor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_62_11			2	0.4	2.04E-04	FCER1G	serotonin secretion by platelet [BP], positive regulation of mast cell cytokine production [BP], negative regulation of mast cell apoptotic process [BP], positive regulation of type III hypersensitivity [BP], positive regulation of type I hypersensitivity [BP], positive regulation of type IIa hypersensitivity [BP], Fc-epsilon receptor I complex [CC], IgE receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_343_11			1	0.2	2.55E-04	HTRA2	pentacyclic triterpenoid metabolic process [BP]
CG_imr90ipsc_promoter_p_PM_12_394_11			3	0.4	3.60E-05	FEM1A, VEGFA	basophil chemotaxis [BP], EP4 subtype prostaglandin E2 receptor binding [MF]
CG_imr90ipsc_promoter_p_PM_12_294_9			3	0.6	1.84E-05	HSD17B2	testosterone 17-beta-dehydrogenase (NAD+) activity [MF], 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_32_19			2	0.4	1.23E-04	SMYD2, SETD8	peptidyl-lysine monomethylation [BP]
CG_imr90ipsc_promoter_p_PM_12_296_17			2	0.4	8.78E-06	TFAP2C	dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP]
CG_imr90ipsc_promoter_p_PM_12_429_6			2	0.4	4.51E-04	GRK1, HPN	regulation of rhodopsin mediated signaling pathway [BP], basement membrane disassembly [BP]
CG_imr90ipsc_promoter_p_PM_12_290_8			1	0.2	1.04E-04	FDFT1, NEIL1, RAD51, DEGS1	damaged DNA binding [MF], endoplasmic reticulum [CC], positive regulation of DNA ligation [BP], farnesyl-diphosphate farnesyltransferase activity [MF], squalene synthase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_403_7			1	0.2	4.71E-04	KIAA1967	DBIRD complex [CC]
CG_imr90ipsc_promoter_p_PM_14_1_18			12	1.0	1.08E-05	SLC6A1, FUT8, BTD	N-glycan fucosylation [BP], biotinidase activity [MF], glycoprotein 6-alpha-L-fucosyltransferase activity [MF], gamma-aminobutyric acid import [BP]
CG_imr90ipsc_promoter_p_PM_12_73_17			3	0.4	4.20E-05	SWI5, PDP2, MLYCD	magnesium-dependent protein serine/threonine phosphatase activity [MF], malonyl-CoA catabolic process [BP], malonyl-CoA decarboxylase activity [MF], acetyl-CoA biosynthetic process [BP], Swi5-Sfr1 complex [CC]
CG_imr90ipsc_promoter_p_PM_12_229_14			2	0.2	2.56E-05	ATCAY, UBE2B	negative regulation of histone phosphorylation [BP], negative regulation of glutamate metabolic process [BP], positive regulation of reciprocal meiotic recombination [BP]
CG_imr90ipsc_promoter_p_PM_12_364_7			2	0.4	1.71E-04	GAA	maltose metabolic process [BP], sucrose metabolic process [BP], diaphragm contraction [BP], vacuolar sequestering [BP]
CG_imr90ipsc_promoter_p_PM_12_49_7			2	0.4	1.88E-04	COL13A1, MAP3K1	JUN kinase kinase activity [MF], collagen type XIII [CC]
CG_imr90ipsc_promoter_p_PM_12_407_6			4	0.8	1.47E-05	CARM1, SLC6A2	histone H3-R17 methylation [BP], histone methyltransferase activity (H3-R17 specific) [MF], norepinephrine:sodium symporter activity [MF]
CG_imr90ipsc_promoter_p_PM_12_95_10			2	0.4	5.01E-04	SLC2A4	amylopectin biosynthetic process [BP], D-glucose transmembrane transporter activity [MF]
CG_imr90ipsc_promoter_p_PM_12_362_7			2	0.4	2.02E-05	POP4	ribonuclease MRP complex [CC]
CG_imr90ipsc_promoter_p_PM_12_270_15			2	0.4	1.35E-04	GLP2R	glucagon receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_348_12			1	0.2	3.45E-05	GNAT1, TRMU, CD4	acyl binding [MF], protein palmitoleylation [BP], positive regulation of cyclic-nucleotide phosphodiesterase activity [BP], tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase activity [MF], induction by virus of host cell-cell fusion [BP]
CG_imr90ipsc_promoter_p_PM_12_44_19			4	0.6	6.89E-05	HDAC9, PGM5, SSTR2, STS, UCHL1, MYOD1	steryl-sulfatase activity [MF], regulation of skeletal muscle fiber development [BP], positive regulation of myoblast fusion [BP], muscle fiber development [BP], cellular response to glucocorticoid stimulus [BP], spot adherens junction [CC], sulfuric ester hydrolase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_89_15			5	0.8	3.48E-05	ACVR1B, GAD1	protein-pyridoxal-5-phosphate linkage [BP], gamma-aminobutyric acid biosynthetic process [BP], positive regulation of trophoblast cell migration [BP], activin receptor activity, type I [MF], glutamate decarboxylation to succinate [BP], glutamate decarboxylase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_454_11			4	0.8	2.66E-05	CD97, GSTP1, PKP3, CTNNB1	desmosome [CC], S-nitrosoglutathione binding [MF], cell adhesion [BP], nitric oxide storage [BP], regulation of fibroblast proliferation [BP], TRAF2-GSTP1 complex [CC], nitric oxide binding [MF], dinitrosyl-iron complex binding [MF]
CG_imr90ipsc_promoter_p_PM_14_4_6			1	0.2	2.94E-05	ACO1, GYG2, HTRA3, ADAMTSL2	negative regulation of transforming growth factor beta receptor signaling pathway [BP], aconitate hydratase activity [MF], glycogenin glucosyltransferase activity [MF], iron-responsive element binding [MF], isocitrate hydro-lyase (cis-aconitate-forming) activity [MF], citrate hydro-lyase (cis-aconitate-forming) activity [MF]
CG_imr90ipsc_promoter_p_PM_12_369_19			3	0.6	1.17E-04	PDZD3	negative regulation of cGMP biosynthetic process [BP], guanylate cyclase inhibitor activity [MF], subapical complex [CC], negative regulation of guanylate cyclase activity [BP]
CG_imr90ipsc_promoter_p_PM_16_10_37			4	0.8	4.38E-05	CFHR5, CFD	complement activation, alternative pathway [BP]
CG_imr90ipsc_promoter_p_PM_12_119_12			4	0.8	1.39E-04	TNFAIP3, RNF4	negative regulation of CD40 signaling pathway [BP], negative regulation of toll-like receptor 5 signaling pathway [BP], protein K48-linked ubiquitination [BP], negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [BP], tolerance induction to lipopolysaccharide [BP], negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [BP]
CG_imr90ipsc_promoter_p_PM_16_39_36			4	0.8	5.91E-05	JMY	'de novo' actin filament nucleation [BP]
CG_imr90ipsc_promoter_p_PM_12_85_11			2	0.4	3.81E-05	PTDSS2, UTS2R, FKBP4	CDP-diacylglycerol-serine O-phosphatidyltransferase activity [MF], steroid hormone receptor complex assembly [BP], urotensin II receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_116_7			4	0.6	5.86E-05	SLC24A3, PDGFRL, SCP2	calcium, potassium:sodium antiporter activity [MF], oleic acid binding [MF], propanoyl-CoA C-acyltransferase activity [MF], lipid hydroperoxide transport [BP], long-chain fatty acyl-CoA binding [MF], positive regulation of intracellular cholesterol transport [BP], platelet-derived growth factor beta-receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_108_10			2	0.4	6.08E-05	CDC42, SLC5A1	apolipoprotein A-I receptor binding [MF], actin filament branching [BP], glucose:sodium symporter activity [MF], submandibular salivary gland formation [BP], positive regulation of hair follicle cell proliferation [BP]
CG_imr90ipsc_promoter_p_PM_12_286_23			2	0.4	1.61E-04	TGFBR1, GSG2	peptidyl-threonine phosphorylation [BP], histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [BP], histone kinase activity (H3-T3 specific) [MF]
CG_imr90ipsc_promoter_p_PM_16_15_27			6	1.0	3.20E-05	ADPRHL2, FURIN, MPST	3-mercaptopyruvate sulfurtransferase activity [MF], poly(ADP-ribose) glycohydrolase activity [MF], negative regulation of low-density lipoprotein particle receptor catabolic process [BP], trans-Golgi network transport vesicle [CC]
CG_imr90ipsc_promoter_p_PM_16_42_14			4	0.8	3.89E-05	C5AR1, OGDH	oxoglutarate dehydrogenase (NAD+) activity [MF], complement component C5a binding [MF]
CG_imr90ipsc_promoter_p_PM_12_210_8			2	0.4	1.18E-04	CYR61, TNFRSF8	positive regulation of TRAIL biosynthetic process [BP], intussusceptive angiogenesis [BP]
CG_imr90ipsc_promoter_p_PM_12_94_9			2	0.4	2.44E-04	MYO6, NOD2, BIRC5	negative regulation of interleukin-18 production [BP], positive regulation of prostaglandin-E synthase activity [BP], interphase microtubule organizing center [CC], positive regulation of dendritic cell cytokine production [BP], detection of muramyl dipeptide [BP], minus-end directed microfilament motor activity [MF], muramyl dipeptide binding [MF]
CG_imr90ipsc_promoter_p_PM_12_69_13			3	0.6	1.09E-04	NOD2	muramyl dipeptide binding [MF], positive regulation of dendritic cell cytokine production [BP], detection of muramyl dipeptide [BP], positive regulation of prostaglandin-E synthase activity [BP], negative regulation of interleukin-18 production [BP]
CG_imr90ipsc_promoter_p_PM_16_34_25			4	0.8	4.66E-05	MTDH, SOD1, SCN8A, CREBRF, FZD3, MARVELD2, CDH1, SPTBN4, BNIP1, EPHB2	node of Ranvier [CC], nuclear body [CC], positive regulation of autophagy [BP], autophagy [BP], axon [CC], commissural neuron axon guidance [BP], sensory perception of sound [BP], transmission of nerve impulse [BP]
CG_imr90ipsc_promoter_p_PM_12_153_7			2	0.4	6.12E-05	BLOC1S3, GET4	endosome to melanosome transport [BP], tail-anchored membrane protein insertion into ER membrane [BP], BAT3 complex [CC]
CG_imr90ipsc_promoter_p_PM_12_416_13			2	0.4	6.10E-05	KHDRBS1	Grb2-Sos complex [CC]
CG_imr90ipsc_promoter_p_PM_12_401_9			1	0.2	1.16E-04	DIO3	thyroxine 5-deiodinase activity [MF]
CG_imr90ipsc_promoter_p_PM_14_30_8			2	0.4	3.24E-05	RUFY3	negative regulation of axonogenesis [BP]
CG_imr90ipsc_promoter_p_PM_14_35_14			3	0.6	9.46E-05	EXTL3	glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_315_5			1	0.2	6.32E-05	KIAA1324, SMCHD1, SPATA18	mitochondrion degradation by induced vacuole formation [BP], positive regulation of vacuole organization [BP], positive regulation of autophagic vacuole assembly [BP], inactivation of X chromosome by DNA methylation [BP]
CG_imr90ipsc_promoter_p_PM_14_42_7			1	0.2	4.44E-05	GAPDHS	glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [MF]
CG_imr90ipsc_promoter_p_PM_12_174_10			2	0.4	2.79E-04	GBAS	negative regulation of ATP citrate synthase activity [BP]
CG_imr90ipsc_promoter_p_PM_12_446_9			2	0.4	8.83E-05	ITGA2, ITGA9	integrin complex [CC], basal part of cell [CC]
CG_imr90ipsc_promoter_p_PM_12_337_7			2	0.4	1.38E-04	BCMO1	beta-carotene 15,15'-monooxygenase activity [MF], vitamin A biosynthetic process [BP]
CG_imr90ipsc_promoter_p_PM_12_223_16			2	0.4	9.04E-05	CACNG3, CACNA1H	voltage-gated calcium channel activity [MF], voltage-gated calcium channel complex [CC], cortisol biosynthetic process [BP], aldosterone biosynthetic process [BP]
CG_imr90ipsc_promoter_p_PM_12_218_5			2	0.4	2.99E-05	DHODH	dihydroorotate oxidase activity [MF], 'de novo' pyrimidine nucleobase biosynthetic process [BP], 'de novo' UMP biosynthetic process [BP], dihydroorotate dehydrogenase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_440_8			1	0.2	1.49E-04	FMN2, BIRC3, MAPK7, HIST1H2BA, WEE2	negative regulation of necroptosis [BP], meiotic chromosome movement towards spindle pole [BP], female pronucleus assembly [BP], female meiosis [BP], oogenesis [BP], inflammatory response [BP], toll-like receptor signaling pathway [BP], negative regulation of oocyte development [BP], meiotic metaphase II [BP]
CG_imr90ipsc_promoter_p_PM_14_21_21			4	0.8	9.55E-05	SIN3B	Y chromosome [CC], autosome [CC]
CG_imr90ipsc_promoter_p_PM_12_182_11			3	0.6	5.64E-05	UBE2B	protein K63-linked ubiquitination [BP], histone H2A ubiquitination [BP]
CG_imr90ipsc_promoter_p_PM_12_463_9			3	0.6	1.16E-04	MTRR	[methionine synthase] reductase activity [MF]
CG_imr90ipsc_promoter_p_PM_14_79_6			1	0.2	4.89E-05	TMEM43, INSIG1, SMAD1	nuclear inner membrane [CC], negative regulation of cargo loading into COPII-coated vesicle [BP]
CG_imr90ipsc_promoter_p_PM_12_173_13			2	0.4	1.41E-04	VCL, MRAP2	protein localization to cell surface [BP]
CG_imr90ipsc_promoter_p_PM_12_397_9			3	0.4	1.89E-04	GSTZ1	maleylacetoacetate isomerase activity [MF]
CG_imr90ipsc_promoter_p_PM_14_56_13			3	0.6	2.21E-05	RARA	Sertoli cell fate commitment [BP]
CG_imr90ipsc_promoter_p_PM_12_98_5			1	0.2	4.56E-05	PKIA, CYP46A1	negative regulation of protein import into nucleus [BP], cholesterol 24-hydroxylase activity [MF]
CG_imr90ipsc_promoter_p_PM_16_14_24			1	0.2	8.25E-05	SDHAF1	mitochondrial respiratory chain complex II assembly [BP]
CG_imr90ipsc_promoter_p_PM_12_238_9			1	0.2	1.36E-04	BMPR1A, CORO1A, MCF2L, PARVB	establishment or maintenance of cell polarity regulating cell shape [BP], negative regulation of actin nucleation [BP], paraxial mesoderm structural organization [BP], lamellipodium [CC], neural plate mediolateral regionalization [BP]
CG_imr90ipsc_promoter_p_PM_14_7_12			2	0.4	4.38E-05	WDYHV1, KLHL20, PIN1	regulation of cytokinesis [BP], interferon-gamma binding [MF], protein-N-terminal glutamine amidohydrolase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_395_8			2	0.4	6.24E-05	LRSAM1	ubiquitin-dependent endocytosis [BP]
CG_imr90ipsc_promoter_p_PM_12_333_5			2	0.4	1.56E-04	SLC5A1	glucose:sodium symporter activity [MF]
CG_imr90ipsc_promoter_p_PM_12_335_11			2	0.4	4.93E-05	DNASE1	deoxyribonuclease I activity [MF]
CG_imr90ipsc_promoter_p_PM_12_467_7			2	0.4	9.38E-05	FAAH	fatty acid amide hydrolase activity [MF]
CG_imr90ipsc_promoter_p_PM_14_37_6			2	0.4	9.46E-06	KAT2B	regulation of protein ADP-ribosylation [BP], lysine N-acetyltransferase activity [MF]
CG_imr90ipsc_promoter_p_PM_14_3_22			3	0.6	8.29E-05	NPM1	regulation of endoribonuclease activity [BP]
CG_imr90ipsc_promoter_p_PM_12_124_14			1	0.2	3.59E-05	CCIN, SACM1L	phosphatidylinositol-4-phosphate phosphatase activity [MF], cytoskeletal calyx [CC]
CG_imr90ipsc_promoter_p_PM_12_136_8			2	0.4	2.82E-05	FDX1, CASQ1, PDP1	terminal cisterna lumen [CC], mitochondrial matrix [CC]
CG_imr90ipsc_promoter_p_PM_12_258_5			1	0.2	1.38E-04	STK36, POR	positive regulation of smoothened signaling pathway [BP], iron-cytochrome-c reductase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_311_7			2	0.4	2.44E-04	PCDHA7, PDZD3, PCDHA10, CASQ1, PCDHA13, PCDHA6	negative regulation of cGMP biosynthetic process [BP], terminal cisterna lumen [CC], subapical complex [CC], homophilic cell adhesion [BP], negative regulation of guanylate cyclase activity [BP], calcium ion binding [MF], guanylate cyclase inhibitor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_22_11			2	0.4	8.49E-05	PPCDC	phosphopantothenoylcysteine decarboxylase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_309_11			2	0.4	2.22E-04	SGPP2	sphingosine-1-phosphate phosphatase activity [MF]
CG_imr90ipsc_promoter_p_PM_12_256_4			1	0.2	2.43E-04	AIF1L, CYP1A2, PCDHB6, PCDHB14, PCDHB13	oxidative deethylation [BP], homophilic cell adhesion [BP], calcium ion binding [MF], calcium-dependent cell-cell adhesion [BP], toxin biosynthetic process [BP], synapse assembly [BP]
CG_imr90ipsc_promoter_p_PM_12_7_25			4	0.6	5.66E-05	BCMO1, AKR1C1	retinal metabolic process [BP]
CG_imr90ipsc_promoter_p_PM_12_151_15			2	0.4	8.81E-05	GRIN1	propylene metabolic process [BP]
CG_imr90ipsc_promoter_p_PM_12_18_19			1	0.2	2.07E-05	ADCYAP1, GPR65	regulation of oligodendrocyte progenitor proliferation [BP], positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway [BP], negative regulation of acute inflammatory response to non-antigenic stimulus [BP], positive regulation of somatostatin secretion [BP], pituitary adenylate cyclase activating polypeptide activity [MF], positive regulation of cAMP biosynthetic process [BP], pituitary adenylate cyclase-activating polypeptide receptor binding [MF]
CG_imr90ipsc_promoter_p_PM_14_15_20			3	0.6	7.76E-05	PPOX, RUVBL2, SLMAP	oxygen-dependent protoporphyrinogen oxidase activity [MF], unfolded protein binding [MF]
CG_imr90ipsc_promoter_p_PM_12_449_17			3	0.6	4.43E-05	VEGFA, SLC2A4	amylopectin biosynthetic process [BP], basophil chemotaxis [BP]
CG_imr90ipsc_promoter_p_PM_12_196_12			1	0.2	2.55E-04	APC	negative regulation of odontogenesis [BP]
CG_imr90ipsc_promoter_p_PM_12_53_17			3	0.6	6.14E-05	CFHR1, CD40LG, FAM20C, FSTL3, SERPINE1, AFM	extracellular space [CC]
CG_imr90ipsc_promoter_p_PM_14_34_13			4	0.8	3.82E-05	NPR1, DLG3, GUCY2D, CANX, OXT	guanylate cyclase activity [MF], positive regulation of renal sodium excretion [BP], receptor guanylyl cyclase signaling pathway [BP], ionotropic glutamate receptor binding [MF]
CG_imr90ipsc_promoter_p_PM_14_19_12			2	0.4	5.92E-05	SLC26A11, SLC26A10	sulfate transmembrane transporter activity [MF], sulfate transport [BP]
CG_imr90ipsc_promoter_p_PM_12_39_9			1	0.2	5.09E-05	KLC2, NLGN3, PAPD7, DYNLRB2	SMC family protein binding [MF], kinesin I complex [CC], regulation of terminal button organization [BP], microtubule motor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_157_10			3	0.6	1.37E-04	HHEX, SLC24A5, FMN2, CLCN3	meiotic chromosome movement towards spindle pole [BP], antiporter activity [MF], hepatic duct development [BP], repressing transcription factor binding [MF]
CG_imr90ipsc_promoter_p_PM_12_212_10			1	0.2	1.55E-04	BCAM, AGBL5	protein branching point deglutamylation [BP], laminin receptor activity [MF]
CG_imr90ipsc_promoter_p_PM_12_137_7			1	0.2	1.77E-04	ARFGEF2, PCDHB16, PCDHB15, PCDHGA9	homophilic cell adhesion [BP], symmetric synapse [CC]